Johnson & Johnson offers to pay $5.5bn to settle baby powder lawsuits
GlobalHealthHigh confidence — 91/100
Johnson & Johnson (J&J) has offered to pay as much as $5.5bn (£4.14bn) to resolve tens of thousands of lawsuits in the US alleging that its baby powder and other products containing talcum cause ovarian cancer.
The proposed landmark settlement aims to close a long-running legal battle that has weighed on the New Jersey-based healthcare giant for years.
J&J has denied that its talc-based products caused cancer and has changed the formula of its widely used baby powder.
Confirmed
Johnson & Johnson (J&J) has offered to pay as much as $5.5bn (£4.14bn) to resolve tens of thousands of lawsuits in the US alleging that its baby powder and other products containing talcum cause ovarian cancer.
The proposed landmark settlement aims to close a long-running legal battle that has weighed on the New Jersey-based healthcare giant for years.
J&J has denied that its talc-based products caused cancer and has changed the formula of its widely used baby powder.